공지 : 도쿄증권거래소 JASDAQ 스탠다드 시장 신규 상장 관련 안내

Global Information
회사소개 | 문의 | 비교리스트

세계의 동물실험 대체법 시장 분석(2021년) : 코로나19(COVID-19)에 의한 성장과 변화(-2030년)

Non-Animal Alternatives Testing Global Market Report 2021: COVID-19 Growth And Change To 2030

리서치사 The Business Research Company
발행일 On Demand Report 상품 코드 1028796
페이지 정보 영문 175 Pages
가격
US $ 4,000 ₩ 4,790,000 PDF (Single User License)
US $ 6,000 ₩ 7,185,000 PDF (Site License)
US $ 8,000 ₩ 9,580,000 PDF (Enterprise License)


세계의 동물실험 대체법 시장 분석(2021년) : 코로나19(COVID-19)에 의한 성장과 변화(-2030년) Non-Animal Alternatives Testing Global Market Report 2021: COVID-19 Growth And Change To 2030
발행일 : On Demand Report 페이지 정보 : 영문 175 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계 동물실험 대체법(Non-Animal Alternatives Testing) 시장의 구조와 동향에 대해 분석했으며, 시장의 주요 특징과 구조, 전체적인 시장 규모·성장률 동향 전망, 부문별(기술별, 최종사용자별)·지역별·주요 국가별 상세 동향, 주요 기업 개요, 최근의 주요 동향, 향후 시장 기회 등에 대해 전해드립니다.

목차

제1장 개요

제2장 동물실험 대체법 시장의 특징

제3장 동물실험 대체법 시장 동향과 전략

제4장 동물실험 대체법 시장에 대한 코로나19(COVID-19)의 영향

제5장 동물실험 대체법 시장 : 시장 규모 및 성장률

  • 시장 규모(단위 : 10억 달러, 2015-2020년)
    • 시장 성장 촉진요인
    • 시장 성장 억제요인
  • 시장 규모(단위 : 10억 달러, 2020-2025년, 2030년)
    • 시장 성장 촉진요인
    • 시장 성장 억제요인

제6장 동물실험 대체법 시장 : 분야별 분석

  • 기술별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)
  • 세포배양 기술
  • 하이스루풋(High throughput) 기술
  • 분자 이미징
  • 오믹스 기술
  • 방법별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)
  • 세포 분석
  • 생화학적 분석
  • In-silico
  • Ex-vivo
  • 최종사용자별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)
  • 제약 업계
  • 화장품/가정용품
  • 진단
  • 화학제품 업계
  • 식품 업계

제7장 동물실험 대체법 시장 : 지역별/국가별 분석

  • 지역별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)
  • 국가별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)

제8장 아시아태평양의 동물실험 대체법 시장

  • 시장 개요
  • 지역 정보
  • 기술별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)
  • 최종사용자별 시장 규모(단위 : 10억 달러, 2015-2020년/2020-2025년/2030년)

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽의 동물실험 대체법 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 동유럽의 동물실험 대체법 시장

제20장 러시아 시장

제21장 북미의 동물실험 대체법 시장

제22장 미국 시장

제23장 남미의 동물실험 대체법 시장

제24장 브라질 시장

제25장 중동의 동물실험 대체법 시장

제26장 아프리카의 동물실험 대체법 시장

제27장 동물실험 대체법 시장 : 경쟁 구도와 기업 개요

  • 경쟁 구도
  • 기업 개요
    • Hµ, Rel Corporation
    • Cyprotex
    • VITROCELL
    • SIMULAB
    • Bio-Rad Laboratories

제28장 동물실험 대체법 시장의 주요 인수합병(M&A)

제29장 동물실험 대체법 시장 : 전망과 잠재력 분석

제30장 부록

LSH 21.09.30

“Non-Animal Alternatives Testing Global Market Report 2021: COVID-19 Growth And Change to 2030” from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global non-animal alternatives testing market.

This report focuses on non-animal alternatives testing market which is experiencing strong growth. The report gives a guide to the non-animal alternatives testing market which will be shaping and changing our lives over the next ten years and beyond, including the markets response to the challenge of the global pandemic.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 12+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the non-animal alternatives testing? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The Non-Animal Alternatives Testing market global report” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider non-animal alternatives testing market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the COVID-19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The non-animal alternatives testing market section of the report gives context. It compares the non-animal alternatives testing market with other segments of the non-animal alternatives testing market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, non-animal alternatives testing indicators comparison.

Scope

Markets Covered:

1) By Technology: Cell Culture Technology; High Throughput Technology; Molecular Imaging; Omics Technology

2) By Method: Cellular Assay; Biochemical Assay; In Silico; Ex-vivo

3) By End-User: Pharmaceutical Industry; Cosmetics & Household Products; Diagnostics; Chemicals Industry; Food Industry

Companies Mentioned: HµRel Corporation; Cyprotex; VITROCELL; SIMULAB; Bio-Rad Laboratories

Countries: Brazil, China, France, Germany, India, Indonesia, Japan, South Korea, Russia, UK, USA, Australia

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Non-Animal Alternatives Testing Market Characteristics

3. Non-Animal Alternatives Testing Market Trends And Strategies

4. Impact Of COVID-19 On Non-Animal Alternatives Testing

5. Non-Animal Alternatives Testing Market Size And Growth

  • 5.1. Global Non-Animal Alternatives Testing Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global Non-Animal Alternatives Testing Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. Non-Animal Alternatives Testing Market Segmentation

  • 6.1. Global Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Cell Culture Technology
  • High Throughput Technology
  • Molecular Imaging
  • Omics Technology
  • 6.2. Global Non-Animal Alternatives Testing Market, Segmentation By Method, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Cellular Assay
  • Biochemical Assay
  • In Silico
  • Ex-vivo
  • 6.3. Global Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Pharmaceutical Industry
  • Cosmetics & Household Products
  • Diagnostics
  • Chemicals Industry
  • Food Industry

7. Non-Animal Alternatives Testing Market Regional And Country Analysis

  • 7.1. Global Non-Animal Alternatives Testing Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global Non-Animal Alternatives Testing Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific Non-Animal Alternatives Testing Market

  • 8.1. Asia-Pacific Non-Animal Alternatives Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 8.3. Asia-Pacific Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China Non-Animal Alternatives Testing Market

  • 9.1. China Non-Animal Alternatives Testing Market Overview
  • 9.2. China Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion
  • 9.3. China Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India Non-Animal Alternatives Testing Market

  • 10.1. India Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 10.2. India Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan Non-Animal Alternatives Testing Market

  • 11.1. Japan Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 11.2. Japan Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia Non-Animal Alternatives Testing Market

  • 12.1. Australia Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 12.2. Australia Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia Non-Animal Alternatives Testing Market

  • 13.1. Indonesia Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 13.2. Indonesia Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea Non-Animal Alternatives Testing Market

  • 14.1. South Korea Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 14.2. South Korea Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe Non-Animal Alternatives Testing Market

  • 15.1. Western Europe Non-Animal Alternatives Testing Market Overview
  • 15.2. Western Europe Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 15.3. Western Europe Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK Non-Animal Alternatives Testing Market

  • 16.1. UK Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 16.2. UK Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany Non-Animal Alternatives Testing Market

  • 17.1. Germany Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 17.2. Germany Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France Non-Animal Alternatives Testing Market

  • 18.4. France Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 18.5. France Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe Non-Animal Alternatives Testing Market

  • 19.1. Eastern Europe Non-Animal Alternatives Testing Market Overview
  • 19.2. Eastern Europe Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 19.3. Eastern Europe Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia Non-Animal Alternatives Testing Market

  • 20.1. Russia Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 20.2. Russia Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America Non-Animal Alternatives Testing Market

  • 21.1. North America Non-Animal Alternatives Testing Market Overview
  • 21.2. North America Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 21.3. North America Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA Non-Animal Alternatives Testing Market

  • 22.1. USA Non-Animal Alternatives Testing Market Overview
  • 22.2. USA Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 22.3. USA Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America Non-Animal Alternatives Testing Market

  • 23.1. South America Non-Animal Alternatives Testing Market Overview
  • 23.2. South America Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 23.3. South America Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil Non-Animal Alternatives Testing Market

  • 24.1. Brazil Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 24.2. Brazil Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East Non-Animal Alternatives Testing Market

  • 25.1. Middle East Non-Animal Alternatives Testing Market Overview
  • 25.2. Middle East Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 25.3. Middle East Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa Non-Animal Alternatives Testing Market

  • 26.1. Africa Non-Animal Alternatives Testing Market Overview
  • 26.2. Africa Non-Animal Alternatives Testing Market, Segmentation By Technology, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 26.3. Africa Non-Animal Alternatives Testing Market, Segmentation By End-User, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. Non-Animal Alternatives Testing Market Competitive Landscape And Company Profiles

  • 27.1. Non-Animal Alternatives Testing Market Competitive Landscape
  • 27.2. Non-Animal Alternatives Testing Market Company Profiles
    • 27.2.1. HµRel Corporation
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Cyprotex
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. VITROCELL
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. SIMULAB
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Bio-Rad Laboratories
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. Key Mergers And Acquisitions In The Non-Animal Alternatives Testing Market

29. Non-Animal Alternatives Testing Market Future Outlook and Potential Analysis

30. Appendix

  • 30.1. Abbreviations
  • 30.2. Currencies
  • 30.3. Research Inquiries
  • 30.4. The Business Research Company
  • 30.5. Copyright And Disclaimer
Back to Top
전화 문의
F A Q